At the Novartis Pensionskasse, one of Switzerland’s leading pension institutions, the mood for risk is muted. Exposure to equities was reduced from 31% at the end of 2002 to 16% a year later; the target for this year is 20%. “The markets are still rather over-valued,” says Gino Pfister, pension ...
Already a registered user or member? Sign in here
Registration also includes access to